Navigation Links
BRCA test results affect patients' breast cancer surgery plans
Date:6/13/2014

PROVIDENCE, R.I. [Brown University] Women diagnosed with breast cancer often face a crucial decision about the extent of their surgical treatment. Many meet national guidelines recommending testing for mutations in the BRCA 1 and 2 genes, which carry a substantial risk of future cancer. A new study reports that among women with breast cancer who undergo recommended testing before surgery, more than 7 in 10 who test positive will change their surgical plan, typically opting for a more extensive procedure such as a double mastectomy and sometimes ovary removal.

"As soon as somebody hears they have a 65 percent chance of a new breast cancer in the future or an up to 60 percent chance of ovarian cancer, they are likely to do whatever they can to prevent that," said lead author Dr. Elizabeth Lokich, an obstetrics and gynecology fellow in the Warren Alpert Medical School of Brown University and at Women & Infants Hospital.

The study appears online in the journal Gynecological Oncology with the recommendation that women who meet National Comprehensive Cancer Network guidelines for genetic testing get the test before deciding on their surgery.

"Particularly because of what we found that it changes their surgical planning it really makes the most sense to have this evaluation done pre-operatively," Lokich said.

The study was based on a retrospective review of the records of 302 Women & Infants breast cancer patients who had undergone preoperative genetic testing between 2006 and 2012 because they met the NCCN guidelines. Within that group, 32 learned that they carried a mutation in their BRCA1 or BRCA2 genes. With that information, 71.9 percent, or 23, of the women who tested positive changed their surgical plan compared to only 28.9 percent of women who tested negative.

Among the mutation carriers, 31.3 percent chose lumpectomies, while 59.4 percent chose double mastectomies and one in eight chose ovary removal. Among women who tested negative, 58.5 percent chose lumpectomies, only 20.7 percent chose double mastectomy and none elected to have their ovaries removed.

Stress and timing

Many women who meet the guidelines do not have a preoperative genetic test, even though it can provide important information. The effect of a positive BRCA mutation test on surgical decision-making had not been studied before and doctors have debated what the best timing should be. Some have argued that testing would add too much stress at a time when women are already coping with learning of their serious diagnosis. Indeed, Lokich acknowledged, some women choose not to be tested.

But Lokich said other studies suggest that genetic testing doesn't add much stress overall.

Instead, the likely reason most women in the study who tested positive for BRCA mutation often changed their surgery plan from lumpectomy to double mastectomy was to prevent a second bout of breast cancer or ovarian cancer.

In the study Lokich and her colleagues found that genetic testing significantly delayed getting to surgery, but not by enough to postpone it past the 90 days post-diagnosis that studies have shown to be clinically significant.

The authors therefore concluded, "We recommend that women meeting NCCN referral guidelines have their genetic evaluation done prior to surgical intervention."


'/>"/>
Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert  

Related medicine news :

1. New therapy for pancreatic cancer patients shows promising results
2. Long-term results encouraging for combination immunotherapy for advanced melanoma
3. Immune therapy for advanced bladder cancer yields promising results
4. EORTC to present cancer research results at ASCO 2014
5. Clinicians urged to consider spironolactone in HFPEF despite TOPCAT results
6. Ataluren Phase 3 trial results in nonsense mutation cystic fibrosis
7. Vibrating capsule shows promising results in treating chronic constipation
8. Automated link to national intervention guidance helps doctors interpret FRAX results
9. Real-world heart procedure results consistent with scientific research
10. Resin infiltration effects in a caries-active environment -- 2 year results
11. Reducing RT dose to bilateral IB lymph nodes results in better patient-reported salivary function
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BRCA test results affect patients' breast cancer surgery plans
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Southland ... line of classic American timber frame barn kits, which can be found on its ... inspired by historic American barn plans, and they highlight the craftsmanship of timber post ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: